A key study worth noting here is the STEP 1 trial, published in the New England Journal of Medicine, which demonstrated that once-weekly semaglutide 2.4mg produced 14.9 percent mean weight loss versus 2.4 percent with placebo in adults with obesity or overweight with at least one weight-related condition
ABOUT THE AUTHORTavishi Dogra Tavishi Dogra is a Deputy Chief Content Producer, Health & Wellness, at Hindustan Times
Our free 3-minute DiabeSCORE quiz analyses your symptoms, lifestyle, and risk factors to give you a personalised metabolic health score and tells you exactly where your GLP-1 system may need support
The real question isn't if they can prescribe it, but if they will
We next tested the interaction of tesofensine and 5-HTP using a variation of the isobolographic assay, with a 1-hour suppression of sucrose intake as the behavioral response
Place your semaglutide in the fridge as soon as you arrive, before you unpack anything else